Physician Assistant in Waterford, PA Accepting Medicare

6 Physician Assistant nurses found. Showing 1 - 6

Stephanie Rademacher, Physician Assistant Medicare: Medicare Enrolled Practice Location: 991 Route 19 N, Suite B, Waterford, PA 16441 Phone: 814-877-8790

Marissa Nichole Altmeyer, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-877-8790    Fax: 814-877-8792

Paige M King, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-877-8790    Fax: 814-877-8792

Caitlin Anne Ebert, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-877-8790    Fax: 814-796-4238

Mercedes A Sundy, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-877-8790    Fax: 814-877-8792

Hanna Marie Swanson, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 991 Route 19 N, Waterford, PA 16441 Phone: 814-877-8790

News Archive

Results of Phase IIb dose range finding of oglemilast in chronic obstructive pulmonary disease announced

Forest Laboratories, Inc. (NYSE: FRX) and Glenmark Pharmaceuticals S.A. (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a Phase IIb dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). Once-daily treatment with oglemilast did not show a statistically meaningful increase from baseline compared to placebo in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in patients with COPD. Oglemilast was well tolerated at all doses studied.

Poor physical function associated with increased risk of dementia in older adults

Poor physical function may be associated with an increased risk for dementia and Alzheimer's disease in elderly adults, according to a report in the May 22 issue of Archives of Internal Medicine.

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

BioScrip®, Inc. today announced 2014 fourth quarter financial results. Fourth quarter revenue from continuing operations was $253.7 million and the net loss from continuing operations was $61.9 million, or $0.90 per basic and diluted share.

Healthy individuals may be at risk for heart disease

In the face of a growing obesity epidemic in the United States, researchers at Wake Forest University Baptist Medical Center have new study results that indicate that how much fat a person has is not as important as where that fat is located when assessing risk for cardiovascular events and metabolic disease.

Read more Medical News

› Verified 7 days ago